Study: Gut microbiome differs according to C. diff symptom status
In a study of children with symptomatic or asymptomatic C. diff, symptom status loomed as the strongest association with differences in gut microbial abundance and diversity.
In a study of children with symptomatic or asymptomatic C. diff, symptom status loomed as the strongest association with differences in gut microbial abundance and diversity.
Vanderbilt Institute for Global Health researchers, in collaboration with Ugandan partners, have received a $2.5 million grant from the Henry M. Jackson Foundation for the Advancement of Military Medicine to study bunyavirus immunity and long-term complications. Paul Blair, MD, MSPH (Infectious Diseases), is a co-investigator of the study.
This year, several Department of Medicine faculty were appointed to new positions that will help advance the department and medical center missions.
Timothy Sterling, MD, professor of Medicine (Infectious Diseases), has received a five-year, $5.7 million grant from the National Institute of Allergy and Infectious Diseases to investigate how Mycobacterium tuberculosis spreads from person to person.
The study was published in JAMA Dermatology by Infectious Disease colleagues, Drs. Elizabeth Phillips and Michelle Martin-Pozo.
Infectious diseases specialist Anna Person, MD, professor of Medicine and director of Education and Faculty Development in the Division of Infectious Diseases, has been named chair of the board of directors of the HIV Medical Association (HIVMA).
VUMC recently held a Directorship Celebration to honor 23 leaders, including seven in the Department of Medicine, from across the enterprise in clinical care, research, education and administration.
According to research recently published in JAMA Dermatology by Elizabeth Phillips, MD, and colleagues, a newly identified genetic marker, HLA-A*34:02, may significantly improve the ability to predict life-threatening reactions to the gout medication allopurinol in U.S. patients.